Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Samantha E. Yohn"'
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
Cognitive impairment is a core symptom of schizophrenia and a major determinant of poor long-term functional outcomes. Despite considerable efforts, we do not yet have any approved pharmacological treatments for cognitive impairment associated with s
Externí odkaz:
https://doaj.org/article/98c84786a3e24a8ea9a6f3a1a70a40c1
Publikováno v:
Trends in Pharmacological Sciences. 43:1098-1112
Modern interest in muscarinic acetylcholine receptor (mAChR) activators for schizophrenia began in the 1990s when xanomeline, an M
Publikováno v:
Biological Psychiatry. 93:S167-S168
Publikováno v:
The American journal of psychiatry. 179(9)
Schizophrenia remains a challenging disease to treat effectively with current antipsychotic medications due to their limited efficacy across the entire spectrum of core symptoms as well as their often burdensome side-effect profiles and poor tolerabi
Publikováno v:
Biological Psychiatry. 91:S286-S287
Autor:
Kristen Gilliland, Anna L. Blobaum, Samantha E. Yohn, P. Jeffrey Conn, Craig W. Lindsley, Michael L. Schulte, Alice L. Rodriguez, Colleen M. Niswender, Mathew T. Loch, Yousuke Yamada
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:2670-2674
This letter describes the further optimization of a series of mGlu3 NAMs based on an N-aryl phenoxyethoxy pyridinone core. A multidimensional optimization campaign, with focused matrix libraries, quickly established challenging SAR, enantiospecific a
Autor:
Alice L. Rodriguez, P. Jeffrey Conn, Allison R. Gregro, Michael Bubser, Mark E. Dugan, Colleen M. Niswender, Leah C. Konkol, Michael W. Wood, Darren W. Engers, Craig W. Lindsley, Jeanette L. Bertron, Bruce J. Melancon, Sean R. Bollinger, Thomas M. Bridges, Samantha E. Yohn, Vincent B. Luscombe, Andrew S. Felts, Michael R. Wood, Carrie K. Jones, Nicholas J. Brandon, Katrina A. Bollinger
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 29:1714-1718
This letter describes progress towards an M4 PAM preclinical candidate that resulted in the discovery of VU6005806/AZN-00016130. While the thieno[2,3-c]pyridazine core has been a consistent feature of key M4 PAMs, no work had previously been reported
Publikováno v:
ACS Chem Neurosci
Accumulated data from clinical and preclinical studies suggest that in drug addiction and states of overeating, such as obesity and binge eating disorder (BED), there is an imbalance in circuits that are critical for motivation, reward saliency, exec
Autor:
Patrick A Randall, Christie A Lee, Eric J Nunes, Samantha E Yohn, Victoria Nowak, Bilal Khan, Priya Shah, Saagar Pandit, V Kiran Vemuri, Alex Makriyannis, Younis Baqi, Christa E Müller, Merce Correa, John D Salamone
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99320 (2014)
Behavioral activation is a fundamental feature of motivation, and organisms frequently make effort-related decisions based upon evaluations of reinforcement value and response costs. Furthermore, people with major depression and other disorders often
Externí odkaz:
https://doaj.org/article/0407af54d2fd4e45885f6af06f13be41
Autor:
David L. McKinzie, Christian C. Felder, Kathryn Fischer, Timothy Meyer, Samantha E. Yohn, Michael Popiolek, Steven M. Paul
Publikováno v:
Biological Psychiatry. 91:S332